Free Trial

Los Angeles Capital Management LLC Sells 888,253 Shares of Exelon Co. (NASDAQ:EXC)

Exelon logo with Utilities background

Los Angeles Capital Management LLC lessened its holdings in shares of Exelon Co. (NASDAQ:EXC - Free Report) by 32.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,835,266 shares of the company's stock after selling 888,253 shares during the quarter. Los Angeles Capital Management LLC owned approximately 0.18% of Exelon worth $69,079,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. State Street Corp grew its stake in shares of Exelon by 3.7% in the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company's stock valued at $2,439,862,000 after buying an additional 2,156,259 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Exelon by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 25,945,791 shares of the company's stock valued at $1,048,823,000 after buying an additional 403,542 shares in the last quarter. FMR LLC grew its stake in shares of Exelon by 18.7% in the 3rd quarter. FMR LLC now owns 11,782,549 shares of the company's stock valued at $477,782,000 after buying an additional 1,858,502 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Exelon by 1.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,967,343 shares of the company's stock valued at $363,626,000 after buying an additional 160,313 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Exelon by 2.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 6,446,408 shares of the company's stock valued at $261,402,000 after buying an additional 123,466 shares in the last quarter. Hedge funds and other institutional investors own 80.92% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Morgan Stanley lowered their price target on Exelon from $46.00 to $44.00 and set an "equal weight" rating for the company in a research note on Friday, November 22nd. BMO Capital Markets restated an "outperform" rating on shares of Exelon in a report on Tuesday, February 4th. Guggenheim upgraded Exelon from a "neutral" rating to a "buy" rating in a report on Thursday, January 23rd. Barclays boosted their target price on Exelon from $42.00 to $48.00 and gave the stock an "overweight" rating in a report on Tuesday. Finally, Evercore ISI upgraded Exelon from an "in-line" rating to an "outperform" rating and boosted their target price for the stock from $43.00 to $44.00 in a report on Tuesday, January 21st. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, Exelon presently has an average rating of "Moderate Buy" and a consensus price target of $44.13.

Get Our Latest Analysis on EXC

Exelon Stock Performance

Shares of EXC stock traded up $0.41 during trading hours on Friday, reaching $44.20. 12,319,512 shares of the company's stock were exchanged, compared to its average volume of 7,400,085. Exelon Co. has a fifty-two week low of $34.01 and a fifty-two week high of $44.46. The stock has a market capitalization of $44.43 billion, a P/E ratio of 18.04, a P/E/G ratio of 2.86 and a beta of 0.56. The business has a fifty day moving average price of $39.99 and a 200-day moving average price of $39.27. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61.

Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, topping analysts' consensus estimates of $0.59 by $0.05. Exelon had a return on equity of 9.52% and a net margin of 10.68%. During the same quarter last year, the firm earned $0.60 earnings per share. Analysts predict that Exelon Co. will post 2.64 EPS for the current fiscal year.

Exelon Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a dividend of $0.40 per share. The ex-dividend date is Monday, February 24th. This is a boost from Exelon's previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.62%. Exelon's payout ratio is currently 65.31%.

Insider Activity

In other news, EVP Colette D. Honorable sold 1,463 shares of the business's stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $40.57, for a total transaction of $59,353.91. Following the sale, the executive vice president now directly owns 2,271 shares in the company, valued at approximately $92,134.47. The trade was a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.10% of the stock is currently owned by company insiders.

Exelon Company Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Stories

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

HIMS Stock Up 120%! More Growth Ahead?

HIMS Stock Up 120%! More Growth Ahead?

Hims & Hers (NYSE: HIMS) has skyrocketed 120% in just a month! Is it the next big disruptor in healthcare, or is it overpriced?

Recent Videos

Congress Cashes In on Stocks—Here’s How You Can Too!
5 Stocks to BUY NOW in March 2025
Archer Aviation: Sinking Now, Soaring Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines